DIAFORMIN XR 500 metformin hydrochloride 500 mg extended release tablet blister pack

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

metformin hydrochloride, Quantity: 500 mg

Commercializzato da:

Alphapharm Pty Ltd

Forma farmaceutica:

Tablet, modified release

Composizione:

Excipient Ingredients: hypromellose; magnesium stearate; carmellose sodium

Via di somministrazione:

Oral

Confezione:

100 Tablets, 30 Tablets, 120 Tablets, 60 Tablets, 10 Tablets (Starter Pack), 90 Tablets

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

Treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. Diaformin XR 500 may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.

Dettagli prodotto:

Visual Identification: White to off-white, round, biconvex tablet, debossed with 500 on one side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Stato dell'autorizzazione:

Registered

Data dell'autorizzazione:

2019-08-08